Nucleai and Merck KGaA will collaborate utilizing Nucleai’s AI-powered platform to develop pathology-based biomarkers as companion diagnostics. Nucleai, a precision
Read more
Insilico Medicine, a Hong Kong-based pioneering biotechnology company, specialising in end-to-end artificial intelligence for target discovery, small molecule chemistry, and
Read more
The legal dispute between the British-Swedish biopharmaceutical giant AstraZeneca and the European Union over a contract to deliver COVID-19 vaccines
Read more
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of the Pfizer-BioNTech vaccine in children aged 12-15
Read more
Danish multinational pharmaceutical company Novo Nordisk and Japanese cardiac regenerative medicine specialist Heartseed have confirmed an exclusive global partnership and license
Read more
GSK and Vir Biotechnology announced that the monoclonal antibody sotrovimab (VIR-7831) has received Emergency Use Authorization (EUA) from the US
Read more
The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has authorized use of the Janssen single-dose COVID-19 vaccine. The
Read more
Engine Biosciences, a company deciphering complex biology to unleash impactful therapeutics plans to use funds from a $43 million funding
Read more
CureVac N.V, a global biopharmaceutical company creating a novel class of revolutionary medicines based on messenger ribonucleic acid (mRNA), revealed
Read more
Charles River Laboratories International confirmed signing a definitive contract to acquire Vigene Biosciences, a leading gene therapy contract development and manufacturing
Read more